ClinicalTrials.gov
ClinicalTrials.gov Menu

Children Immune Functions

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01717534
Recruitment Status : Completed
First Posted : October 30, 2012
Last Update Posted : August 27, 2013
Sponsor:
Information provided by (Responsible Party):
Nestlé

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The purpose of the planned study is to investigate the effect of heat-treated lactobacilli on diarrhea outcome in healthy children 1-4 years old in a randomized, double-blind, placebo-controlled study.

Condition or disease Intervention/treatment Phase
Diarrhea Upper Respiratory Infections Dietary Supplement: heat-treated lactobacilli or placebo Not Applicable

Detailed Description:
The beneficial effect of heat-treated lactobacilli for treatment of symptomatic diarrhea was clearly documented and the purpose of this planned study is to investigate the effect on reduction of days with diarrhea in a preventive setting in healthy children 1-4 years old. Moreover, the study is intended to evaluate the impact on the immune status of the children.

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 374 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: A Randomized, Double-blind, Placebo-controlled Study to Investigate the Effect of Heat-treated Lactobacilli on Infections and Immune Status in Healthy Children
Study Start Date : October 2012
Actual Primary Completion Date : July 2013
Actual Study Completion Date : July 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Diarrhea

Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: Heat-treated lactobacilli

One sachets (1 gram of content) will be consumed once a day, and will be suspended in a provided milk powder to be reconstituted with water.

The duration of the treatment is 5 months.

 Dietary Supplement: heat-treated lactobacilli or placebo
Daily supplement of sachet with 1 g of powder over a 5 months period.
Placebo Comparator: Maltodextrin

One sachets (1 gram of content) will be consumed once a day, and will be suspended in a provided milk powder to be reconstituted with water.

The duration of the treatment is 5 months.

 Dietary Supplement: heat-treated lactobacilli or placebo
Daily supplement of sachet with 1 g of powder over a 5 months period.


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Days with diarrhea [ Time Frame: during 5 months of study period ]

Secondary Outcome Measures :
  1. Number of episodes of upper respiratory infections [ Time Frame: during 5 months ]
  2. Duration of upper respiratory infections [ Time Frame: during 5 months ]
  3. Severity of upper respiratory infections [ Time Frame: during 5 months ]
  4. Severity of gastrointestinal infections [ Time Frame: during 5 months ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   12 Months to 48 Months   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Parents written and signed informed consent for participation in the study: parents agree with the participation in the study, dated and signed informed consent form prior to any study related procedure.
  2. Healthy children aged 1 to 4 years
  3. No more breastfed.
  4. Daily home cared and going to a selected pediatrician.
  5. Parents must have a phone at home or a cellular phone to call the paediatrician.
  6. No consumption of commercial products containing probiotics and / or prebiotics during the 3 weeks before and during the study period.
  7. Children not being intensive consumers of regular yoghurts
  8. Parents are able to keep a daily record of symptoms and to administrate the study products.

Exclusion Criteria:

  1. Vaccine administration within the last 3 months prior study start.
  2. Used antibiotics within the last month
  3. Congenital or chronic disease.
  4. Any kind of immunodeficiency or allergy.
  5. Acute infection or fever.
  6. Significant illness within the two weeks prior to the start of the study.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01717534


Locations
Mexico
Clinical Research Institute
Tlalnepantla, Edo. De Méx, Mexico, 54055
Centro de Estudios Clinicos de Queretaro S.c.
Querétaro, Qro, Mexico, 76000
Sponsors and Collaborators
Nestlé
Investigators
Principal Investigator: Angeles Nava Hernández, MD Center of Clinical Research of Querétaro
Principal Investigator: Carlos A. Mena Cedillos, MD Clinical Research Institute
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Responsible Party: Nestlé
ClinicalTrials.gov Identifier: NCT01717534     History of Changes
Other Study ID Numbers: 10.42.NRC
First Posted: October 30, 2012    Key Record Dates
Last Update Posted: August 27, 2013
Last Verified: August 2013

Keywords provided by Nestlé:
Diarrhea
Children
Heat-treated lactobacilli

Additional relevant MeSH terms:
Infection
Diarrhea
Respiratory Tract Infections
 Signs and Symptoms, Digestive
Signs and Symptoms
Respiratory Tract Diseases